557 related articles for article (PubMed ID: 16236334)
21. Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons.
Baptista V; Varanda WA
J Neurophysiol; 2005 Jul; 94(1):147-52. PubMed ID: 15744010
[TBL] [Abstract][Full Text] [Related]
22. Factors that enhance ethanol inhibition of N-methyl-D-aspartate receptors in cerebellar granule cells.
Popp RL; Lickteig RL; Lovinger DM
J Pharmacol Exp Ther; 1999 Jun; 289(3):1564-74. PubMed ID: 10336554
[TBL] [Abstract][Full Text] [Related]
23. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
24. Differential responses to NMDA receptor activation in rat hippocampal interneurons and pyramidal cells may underlie enhanced pyramidal cell vulnerability.
Avignone E; Frenguelli BG; Irving AJ
Eur J Neurosci; 2005 Dec; 22(12):3077-90. PubMed ID: 16367774
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
26. D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent.
Beazely MA; Tong A; Wei WL; Van Tol H; Sidhu B; MacDonald JF
J Neurochem; 2006 Sep; 98(5):1657-63. PubMed ID: 16879713
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of N-methyl-D-aspartate receptors increases paraoxon-induced apoptosis in cultured neurons.
Wu X; Tian F; Okagaki P; Marini AM
Toxicol Appl Pharmacol; 2005 Oct; 208(1):57-67. PubMed ID: 16164961
[TBL] [Abstract][Full Text] [Related]
28. BDNF-induced facilitation of afferent-evoked responses in lamina II neurons is reduced after neonatal spinal cord contusion injury.
Garraway SM; Anderson AJ; Mendell LM
J Neurophysiol; 2005 Sep; 94(3):1798-804. PubMed ID: 15901762
[TBL] [Abstract][Full Text] [Related]
29. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
30. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
31. Is NMDA receptor activation essential for the production of locomotor-like activity in the neonatal rat spinal cord?
Cowley KC; Zaporozhets E; Maclean JN; Schmidt BJ
J Neurophysiol; 2005 Dec; 94(6):3805-14. PubMed ID: 16120672
[TBL] [Abstract][Full Text] [Related]
32. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
33. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
34. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
35. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
Whittemore ER; Ilyin VI; Woodward RM
J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
37. Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro.
Wegner F; Kraft R; Busse K; Schaarschmidt G; Härtig W; Schwarz SC; Schwarz J
J Neurochem; 2009 Oct; 111(1):204-16. PubMed ID: 19659571
[TBL] [Abstract][Full Text] [Related]
38. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
39. Lipid emulsions reduce NMDA-evoked currents.
Weigt H; Georgieff M; Beyer C; Georgieff EM; Kuhse J; Föhr KJ
Neuropharmacology; 2004 Sep; 47(3):373-80. PubMed ID: 15275826
[TBL] [Abstract][Full Text] [Related]
40. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
Gonzales RA; Roper LC; Westbrook SL
J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
